Jim Simons Ac Immune Sa Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ac Immune Sa stock. As of the latest transaction made, Renaissance Technologies LLC holds 740,198 shares of ACIU stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

740,198

Previous 646,007 14.58%

Holding current value

$1.96 Million

Previous $2.44 Million 18.15%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$2.67 - $3.75 $251,489 - $353,216	94,191 Added 14.58%	740,198 $2 Million
Q3 2024 Nov 13, 2024	SELL	$2.99 - $4.2 $18,155 - $25,502	-6,072 Reduced 0.93%	646,007 $2.44 Million
Q2 2024 Aug 09, 2024	BUY	$2.29 - $4.87 $312,127 - $663,781	136,300 Added 26.43%	652,079 $2.6 Million
Q1 2024 May 13, 2024	BUY	$2.66 - $4.87 $261,212 - $478,234	98,200 Added 23.52%	515,779 $1.53 Million
Q4 2023 Feb 13, 2024	SELL	$2.46 - $5.0 $18,696 - $38,000	-7,600 Reduced 1.79%	417,579 $2.09 Million
Q3 2023 Nov 14, 2023	BUY	$2.77 - $3.38 $19,944 - $24,336	7,200 Added 1.72%	425,179 $1.21 Million
Q2 2023 Aug 11, 2023	BUY	$1.85 - $3.4 $12,765 - $23,460	6,900 Added 1.68%	417,979 $1.24 Million
Q1 2023 May 12, 2023	BUY	$2.13 - $2.49 $13,632 - $15,936	6,400 Added 1.58%	411,079 $962,000
Q4 2022 Feb 13, 2023	SELL	$1.72 - $3.12 $51,944 - $94,224	-30,200 Reduced 6.94%	404,679 $826,000
Q3 2022 Nov 14, 2022	SELL	$2.4 - $3.64 $95,306 - $144,548	-39,711 Reduced 8.37%	434,879 $1.37 Million
Q2 2022 Aug 12, 2022	BUY	$2.35 - $4.47 $51,935 - $98,787	22,100 Added 4.88%	474,590 $1.71 Million
Q1 2022 May 13, 2022	BUY	$3.5 - $5.16 $36,050 - $53,148	10,300 Added 2.33%	452,490 $1.81 Million
Q4 2021 Feb 11, 2022	BUY	$4.83 - $7.56 $84,525 - $132,300	17,500 Added 4.12%	442,190 $2.19 Million
Q3 2021 Nov 12, 2021	SELL	$6.2 - $8.34 $9,300 - $12,510	-1,500 Reduced 0.35%	424,690 $2.85 Million
Q2 2021 Aug 13, 2021	SELL	$6.04 - $8.37 $604 - $836	-100 Reduced 0.02%	426,190 $3.38 Million
Q1 2021 May 13, 2021	SELL	$5.32 - $8.96 $810,076 - $1.36 Million	-152,270 Reduced 26.32%	426,290 $3.24 Million
Q4 2020 Feb 10, 2021	SELL	$4.47 - $5.58 $320,279 - $399,812	-71,651 Reduced 11.02%	578,560 $2.99 Million
Q3 2020 Nov 13, 2020	SELL	$4.78 - $9.06 $649,124 - $1.23 Million	-135,800 Reduced 17.28%	650,211 $3.17 Million
Q2 2020 Aug 13, 2020	BUY	$6.57 - $8.3 $714,159 - $902,210	108,700 Added 16.05%	786,011 $5.29 Million
Q1 2020 May 14, 2020	BUY	$4.24 - $9.89 $805,214 - $1.88 Million	189,909 Added 38.96%	677,311 $4.68 Million
Q4 2019 Feb 13, 2020	BUY	$4.56 - $8.78 $489,287 - $942,093	107,300 Added 28.23%	487,402 $4.15 Million
Q3 2019 Nov 13, 2019	BUY	$4.8 - $5.89 $633,902 - $777,851	132,063 Added 53.24%	380,102 $1.88 Million
Q2 2019 Aug 12, 2019	BUY	$4.72 - $5.88 $131,164 - $163,399	27,789 Added 12.62%	248,039 $1.38 Million
Q1 2019 May 14, 2019	BUY	$3.65 - $11.68 $548,777 - $1.76 Million	150,350 Added 215.09%	220,250 $1.11 Million
Q4 2018 Feb 13, 2019	BUY	$7.35 - $11.7 $513,765 - $817,830	69,900 New	69,900 $661,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

27.8M

Call Options Held

31.3K

Put Options Held

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $221M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account